Featured Funding Opportunities
University Hospital Foundation Medical Research Competition (UHFMRC)
This competition funds innovative, translational research in the FoMD with clear linkage to clinical care of adults. The registration deadline is Monday, September 24 and full application deadline is Tuesday, October 9, 2018before 4:00pm.
For more details see the attached guidelines.
Komen Call For Research Proposals Focused On Conquering Metastatic Breast Cancer From Early Career Investigators
Career Catalyst Research (CCR) Grants
- Eligibility: Applications are open to early career investigators working at academic institutions who have held faculty positions for no more than 5 years.
- Funding Level: Up to $150,000 per year for up to 3 years.
- Training Requirements: Applicants/PIs must propose a mentor committee whose purpose is to provide the research, scientific, clinical, management, and leadership guidance necessary to foster the Applicant’s career advancement.
At least one mentor, designated as the Lead Mentor, must be at the same institution as the PI and serve as the onsite representative for the entire mentor committee.
- Grant Intent: CCR Grants provide unique opportunities for scientists or clinician scientists who have held faculty positions for no more than five years by the Application due date (October 17, 2018). CCR grants provide support for hypothesis-driven research projects that will lead to a reduction in breast cancer deaths by 2026.
- Research Focus Area: Conquering Metastatic Breast Cancer. The goal of this focus area is to support outstanding translational research into the understanding, detection, and treatment of metastatic breast cancer which will lead to a reduction in breast cancer deaths by 2026. Applications that fit the focus area as detailed in the LOI Announcement and include studies that address metastatic breast cancer disparities or leverage data science to better understand and treat metastatic breast cancer are highly encouraged.
KEY DATES
- Application System Opens: July 2, 2018
- Letter of Intent Due:August 1, 2018, by1 p.m., Eastern Standard Time
- Letter of Intent Decision:August 22, 2018
- Application Due:October 17, 2018, by1 p.m., Eastern Standard Time
- Award Notification: On or aroundApril 15, 2019
PATIENT VOICE
As part of Komen’s commitment to include the patient perspective, applicants are required to work with Patient Advocates when submitting an Application (dueOctober 17, 2018).
Details on the Funding Mechanism is available at www.komen.org/RFA.
Dr. Cyril M Kay Graduate Studentship
The Alberta Cancer Foundation and Cancer Research Institute of Northern Alberta have partnered to offer the Dr. Cyril M Kay Graduate Studentship. This award was established to recognize a high caliber student registered in a Masters or Ph.D. degree program at the University of Alberta, focusing on cancer research.
This scholarship provides a stipend in the amount of $27,000 per annum for a maximum of two (2) years plus research allowance in the amount of $1,500 paid in the first year which can be spent over the period of 2 years.
Eligibility:
1. Applicant and Supervisor must be CRINA members
2. Scholarship cannot be held with other major awards
The successful candidate can use the research allowance as follows:
1. Materials and supplies
2. Travel to scientific meetings and conferences directly related to the project that the trainee is working on
Ineligible expenses are:
1. Health Insurance
2. Equipment
3. Tuition Fees
Instructions:
1. Complete application form
2. Upload supporting documents in PDF format - Transcripts will have to be compiled into one PDF file
3. Three letters of reference will have to be emailed to crina@ualberta.ca directly by the faculty member providing the reference letter.
Application deadline: July 26 at 4:00 pm MST
If you have any questions/concerns please contact us at crina@ualberta.ca
Astellas Oncology C3Prize®
Astellas Oncology C3 Prize® is kicking off its third year and the application period is now open! This year, there’s a special focus on addressing the needs of those in low-and middle-income countries, which bear a disproportionate burden of the global cancer epidemic.
Astellas Oncology is inviting healthcare innovators to propose ideas that address specific challenges encountered in low- and middle-income countries within the following three categories: support tools, educational tools and technology. The three category winners will be flown to Kuala Lumpur to compete in a live pitch before a panel of judges at the Union for International Cancer Control (UICC) World Cancer Congress onOctober 3, 2018.
Following the live pitch, prizes totaling $100,000 USD will be awarded to the three winners - one $50,000 USD grand prize and two $25,000 USD grants. Winners will also receive a one-year “nights and weekends” membership to MATTER, a Chicago-based healthcare innovation community, to help bring their ideas to life. More information about the awards and submission criteria can be found at:www.c3prize.com. Entries will be accepted throughJuly 25, 2018.
We also have a suggested social media post below and have aDropbox folder with the fact sheet and an example newsletter in case you would like to share this information via those channels.
If you have any questions, feel free to reach out via email or at 416-425-9143 x203. Additionally, you can find more information, including full terms and conditions and eligibility, atwww.C3Prize.com.
This is up to $2.2M for a team with a minimum of three PIs.
LOIs are dueJuly 13, 2018.
For more information seehere and the attached request for applications.
Pfizer is proud to introduce the CANADIAN Advancing Science through Pfizer Investigator Research Exchange (ASPIRE) 2018 Breast Cancer Research Awards, a Competitive Grants Program Supported by Pfizer for investigators in Canada.
Call for Research Proposals
For complete information about the program, please visit ASPIRE website www.canadaaspire.org
AREA OF RESEARCH FOCUS
Pfizer invites investigators to apply for the 2018 Canadian ASPIRE Breast Cancer Research Awards through submission of innovative clinical research proposals designed to accomplish the mission of advancing knowledge in the treatment and disease management of breast cancer.
AWARDS
The 2018 Canadian ASPIRE Breast Cancer Research Awards Program will have 2 categories of Award(s):
Breast Cancer Research Award
Early Investigator Award (within 5 years of residency completion for MD, or 5 years of 1st faculty position for non-MD).
The maximum budget allowed per proposal will be $200,000 (including a maximum of 30% overhead).
The 2018 Canadian ASPIRE Breast Cancer Research Awards Program intends to fund at least 2 proposals.
Winners expected to be announced by the end of January 2019.
SUBMISSIONS ARE DUE BY
September 24, 2018
2018 Alberta Innovates Training & Early Career Development Program Announcement
We are pleased to inform you that the 2018 Training and Early Career Development (TECD) competitions are now open. We will be offering all four streams in this competition – Graduate Studentship, MD-PhD Studentship, Postgraduate Fellowship and Clinician Fellowship. The deadline for application into these competitions is September 7, 2018 at 4pm MDT.
We anticipate funding only up to 20 applications total across the portfolio – as such, the competition for the awards in each category will be very significant.
We have updated the eligibility / program guides for all the programs. I have highlighted the specific changes below and additional detail can be found on our website:
- No out of province awards will be considered. All applicants must be training at an Alberta University
- All awards must be implemented by either January 1, 2019, February 1, 2019 or March 1, 2019.
- Graduate Studentships
- Maximum eligibility 3 years
- Maximum eligibility 1 year for Masters level
- MD-PhD Studentship
- Maximum eligibility 5 years
If you have any questions please do not hesitate to contact Kathy Morrison – she can be reached at Kathy.morrison@albertainnovates.ca or by phone at 780-429-7655.
FY2018 Funding opportunities have now been posted.
The Alberta Cancer Foundation is partnering with two other organizations for an exciting new investment opportunity. The Cancer Detection Challenge is led by Alberta Innovates, and sponsored by Alberta Cancer Foundation and DynaLIFE Medical Labs. They are inviting members of the Alberta cancer technology, research and clinical communities to identify and support the development of technology to detect and diagnose cancer earlier, improving outcomes for Alberta patients with cancer. The Challenge is broad in scope, inclusionary of technologies across the cancer detection pathway and agnostic to cancer-type. The focus of this call is on detection technologies that can be applied in a laboratory setting, however, other modalities will be considered such as imaging. Applicants must be for-profit companies but can have academic co-applicants.
Current funding opportunities from some of the CCRA member organizations are listed in this link. Organizations are listed in alphabetical order. Please note that this is not a comprehensive list.